SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kastrati A) srt2:(2015-2019)"

Sökning: WFRF:(Kastrati A) > (2015-2019)

  • Resultat 11-20 av 21
  • Föregående 1[2]3Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Byrne, Robert A, et al. (författare)
  • Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention : executive summary
  • 2018
  • Ingår i: European Heart Journal. - : EUROPA EDITION. - 0195-668X .- 1522-9645. ; 13:13, s. 1574-1586
  • Tidskriftsartikel (refereegranskat)abstract
    • A previous Task Force of the European Society of Cardiology (ESC) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) provided a report on recommendations for the non-clinical and clinical evaluation of coronary stents. Following dialogue with the European Commission, the Task Force was asked to prepare an additional report on the class of devices known as bioresorbable scaffolds (BRS). Five BRS have CE-mark approval for use in Europe. Only one device-the Absorb bioresorbable vascular scaffold-has published randomized clinical trial data and this data show inferior outcomes to conventional drug-eluting stents (DES) at 2-3 years. For this reason, at present BRS should not be preferred to conventional DES in clinical practice. The Task Force recommends that new BRS devices should undergo systematic non-clinical testing according to standardized criteria prior to evaluation in clinical studies. A clinical evaluation plan should include data from a medium sized, randomized trial against DES powered for a surrogate end point of clinical efficacy. Manufacturers of successful devices receive CE-mark approval for use and must have an approved plan for a large-scale randomized clinical trial with planned long-term follow-up.
  •  
12.
  • Kessler, Thorsten, et al. (författare)
  • Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention
  • 2019
  • Ingår i: Cardiovascular Research. - : OXFORD UNIV PRESS. - 0008-6363 .- 1755-3245. ; 115:10, s. 1512-1518
  • Tidskriftsartikel (refereegranskat)abstract
    • Aim A common genetic variant at the GUCY1A3 coronary artery disease locus has been shown to influence platelet aggregation. The risk of ischaemic events including stent thrombosis varies with the efficacy of aspirin to inhibit platelet reactivity. This study sought to investigate whether homozygous GUCY1A3 (rs7692387) risk allele carriers display higher on-aspirin platelet reactivity and risk of ischaemic events early after coronary intervention. Methods and results The association of GUCY1A3 genotype and on-aspirin platelet reactivity was analysed in the genetics substudy of the ISAR-ASPI registry (n = 1678) using impedance aggregometry. The clinical outcome cardiovascular death or stent thrombosis within 30 days after stenting was investigated in a meta-analysis of substudies of the ISAR-ASPI registry, the PLATO trial (n = 3236), and the Utrecht Coronary Biobank (n = 1003) comprising a total 5917 patients. Homozygous GUCY1A3 risk allele carriers (GG) displayed increased on-aspirin platelet reactivity compared with non-risk allele (AA/AG) carriers [150 (interquartile range 91-209) vs. 134 (85-194) AU.min, P < 0.01]. More homozygous risk allele carriers, compared with non-risk allele carriers, were assigned to the high-risk group for ischaemic events (>203AU.min; 29.5 vs. 24.2%, P = 0.02). Homozygous risk allele carriers were also at higher risk for cardiovascular death or stent thrombosis (hazard ratio 1.70, 95% confidence interval 1.08-2.68; P = 0.02). Bleeding risk was not altered. Conclusion We conclude that homozygous GUCY1A3 risk allele carriers are at increased risk of cardiovascular death or stent thrombosis within 30 days after coronary stenting, likely due to higher on-aspirin platelet reactivity. Whether GUCY1A3 genotype helps to tailor antiplatelet treatment remains to be investigated.
  •  
13.
  • Rosén, Jörgen, et al. (författare)
  • The effect of immersive virtual reality on proximal and conditioned threat
  • 2019
  • Ingår i: Scientific Reports. - 2045-2322 .- 2045-2322. ; 9
  • Tidskriftsartikel (refereegranskat)abstract
    • Virtual reality lets the user be immersed in a 3-dimensional environment, which can enhance certain emotional responses to stimuli relative to experiencing them on a flat computer screen. We here tested whether displaying two different types of threats in immersive virtual reality enhanced threat related autonomic responses measured by skin conductance responses (SCRs). We studied innate and learned threat responses because these types of threats have been shown to depend on different neural circuits in animals. Therefore, it is possible that immersive virtual reality may modulate one of these threats but not the other. Innate threat responses were provoked by the sudden appearance of characters at proximal egocentric distance, which were compared to the sudden appearance of distant characters (proximal threat). Learned threat responses were studied by conditioning two of the characters to an electric shock (conditioned threat) and contrasting SCRs to these characters with SCRs to two other characters that were never paired with shock. We found that displaying stimuli in immersive virtual reality enhanced proximal threat responses but not conditioned threat responses. Findings show that immersive virtual reality can enhance an innate type of threat responses without affecting a learned threat response, suggesting that separate neural pathways serve these threat responses.
  •  
14.
  • Byrne, Robert A., et al. (författare)
  • Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe : executive summary
  • 2015
  • Ingår i: European Heart Journal. - 0195-668X .- 1522-9645. ; 36:38, s. 2608-2620
  • Tidskriftsartikel (refereegranskat)abstract
    • The evaluation for European Union market approval of coronary stents falls under the Medical Device Directive that was adopted in 1993. Specific requirements for the assessment of coronary stents are laid out in supplementary advisory documents. In response to a call by the European Commission to make recommendations for a revision of the advisory document on the evaluation of coronary stents (Appendix 1 of MEDDEV 2.7.1), the European Society of Cardiology (ESC) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) established a Task Force to develop an expert advisory report. As basis for its report, the ESC-EAPCI Task Force reviewed existing processes, established a comprehensive list of all coronary drug-eluting stents that have received a CE mark to date, and undertook a systematic review of the literature of all published randomized clinical trials evaluating clinical and angiographic outcomes of coronary artery stents between 2002 and 2013. Based on these data, the TF provided recommendations to inform a new regulatory process for coronary stents. The main recommendations of the task force include implementation of a standardized non-clinical assessment of stents and a novel clinical evaluation pathway for market approval. The two-stage clinical evaluation plan includes recommendation for an initial pre-market trial with objective performance criteria (OPC) benchmarking using invasive imaging follow-up leading to conditional CE-mark approval and a subsequent mandatory, large-scale randomized trial with clinical endpoint evaluation leading to unconditional CE-mark. The data analysis from the systematic review of the Task Force may provide a basis for determination of OPC for use in future studies. This paper represents an executive summary of the Task Force's report.
  •  
15.
  •  
16.
  •  
17.
  • Stender, Joshua D, et al. (författare)
  • Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells
  • 2017
  • Ingår i: Molecular Cell. - Cambridge, United States : Cell Press. - 1097-2765 .- 1097-4164. ; 65:6, s. 1122-1135.e5
  • Tidskriftsartikel (refereegranskat)abstract
    • Human breast cancers that exhibit high proportions of immune cells and elevated levels of pro-inflammatory cytokines predict poor prognosis. Here, we demonstrate that treatment of human MCF-7 breast cancer cells with pro-inflammatory cytokines results in ERα-dependent activation of gene expression and proliferation, in the absence of ligand or presence of 4OH-tamoxifen (TOT). Cytokine activation of ERα and endocrine resistance is dependent on phosphorylation of ERα at S305 in the hinge domain. Phosphorylation of S305 by IKKβ establishes an ERα cistrome that substantially overlaps with the estradiol (E2)-dependent ERα cistrome. Structural analyses suggest that S305-P forms a charge-linked bridge with the C-terminal F domain of ERα that enables inter-domain communication and constitutive activity from the N-terminal coactivator-binding site, revealing the structural basis of endocrine resistance. ERα therefore functions as a transcriptional effector of cytokine-induced IKKβ signaling, suggesting a mechanism through which the tumor microenvironment controls tumor progression and endocrine resistance.
  •  
18.
  •  
19.
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 21
  • Föregående 1[2]3Nästa
Typ av publikation
tidskriftsartikel (21)
Typ av innehåll
refereegranskat (20)
övrigt vetenskapligt (1)
Författare/redaktör
Kastrati, Adnan (16)
Byrne, Robert A. (9)
Kastrati, A (8)
Windecker, Stephan (7)
Loos, Ruth J F (7)
Schunkert, Heribert (7)
visa fler...
Kessler, Thorsten (7)
Roffi, Marco (6)
Bueno, Héctor (6)
Jüni, Peter (6)
Nelson, Christopher ... (6)
Valgimigli, Marco (6)
Zeng, Lingyao (6)
Collet, Jean-Philipp ... (5)
Samani, Nilesh J. (5)
Palmer, Colin N. A. (5)
Erdmann, Jeanette (5)
Esko, Tonu (5)
Bottinger, Erwin P. (5)
Howson, Joanna M. M. (5)
Kolh, Philippe (4)
Zamorano, Jose Luis (4)
Wareham, Nicholas J (4)
Ahlsson, A (4)
Montalescot, Gilles (4)
Steg, Philippe Gabri ... (4)
Jeppsson, Anders, 19 ... (4)
Schunkert, H. (4)
Farrall, Martin (4)
Benedetto, U (4)
Roden, Dan M. (4)
Kathiresan, Sekar (4)
Niebauer, J (4)
Asselbergs, Folkert ... (4)
Mueller-Nurasyid, Ma ... (4)
Hall, Alistair S. (4)
Watkins, Hugh (4)
Rader, Daniel J. (4)
Alfonso, F. (4)
Falk, V (4)
Windecker, S (4)
Collet, JP (4)
Juni, P (4)
Richter, DJ (4)
Kristensen, SD (4)
Goel, Anuj (4)
Lu, Yingchang (4)
Mauri, Laura (4)
Zeng, LY (4)
Stefanini, Giulio G. (4)
visa färre...
Lärosäte
Uppsala universitet (9)
Karolinska Institutet (6)
Göteborgs universitet (5)
Lunds universitet (4)
Umeå universitet (3)
Linköpings universitet (1)
visa fler...
Mittuniversitetet (1)
visa färre...
Språk
Engelska (21)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (13)
Samhällsvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy